Ադենոկախյալ վիրուս (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ադենոկախյալ վիրուս" in Armenian language version.

refsWebsite
Global rank Armenian rank
4th place
3rd place
1st place
1st place
5,233rd place
3,814th place
1,389th place
284th place
28th place
128th place

cnn.com

ictvonline.org

nih.gov

ncbi.nlm.nih.gov

  • Grieger, JC; Samulski, RJ (2005), «Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.», Advances in biochemical engineering/biotechnology, Berlin, Germany (99): 119–145, PMID 16568890
  • Surosky, RT; Urabe, M; Godwin, SG; և այլք: (1997), «Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome», Journal of virology, 71 (10), PMID 9311886 {{citation}}: Explicit use of et al. in: |given3= (օգնություն); Text "Volume" ignored (օգնություն)
  • Chirmule, N; Propert, K; Magosin, S; և այլք: (1999), «Immune responses to adenovirus and adeno-associated virus in humans», Gene therapy (September): 1574–83, PMID 10490767 {{citation}}: Explicit use of et al. in: |given3= (օգնություն)
  • Hernandez, YJ; Wang, J; Kearns, WG; և այլք: (1999), «Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model», Journal of virology (October): 8549–58, PMID 10482608 {{citation}}: Explicit use of et al. in: |given3= (օգնություն)
  • Ponnazhagan, S; Mukherjee, P; Yoder, MC; և այլք: (1997), «Adeno-associated virus 2-mediated gene transfer in vivo: organ-tropism and expression of transduced sequences in mice», Gene (ապրիլի 29): 203–10, PMID 9185868 {{citation}}: Explicit use of et al. in: |given3= (օգնություն)
  • Carter, BJ (2005), «Adeno-Associated Virus Vectors in Clinical Trials», Human Gene Therapy, 16: 541–50, PMID 15916479
  • Kaplitt, MG; Feigin, A; During, MJ; others (2007), «Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial», Lancet, 369: 2097–2105, PMID 17586305
  • Bohenzky, RA; LeFebvre, RB; Berns, KI (1988), «Sequence and symmetry requirements within the internal palindromic sequences of the adeno-associated virus terminal repeat», Virology, San Diego: Academic Press, 166 (2), PMID 2845646
  • Wang, X.S.; Ponnazhagan; Srivastava (1995), «Rescue and replication signals of the adeno-associated virus 2 genome», Journal of Molecular Biology, 250: 573–80, PMID 7623375 {{citation}}: Unknown parameter |Given2= ignored (|given2= suggested) (օգնություն); Unknown parameter |Given3= ignored (|given3= suggested) (օգնություն); Unknown parameter |Issue= ignored (|issue= suggested) (օգնություն)
  • Weitzman, MD; Kyostio, SR; Kotin, RM; Owens, RA (1994), «Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA», Proceedings of the National Academy of Sciences of the United States of America, 91 (13): 5808–12, PMID 8016070
  • Zhou, X; Muzyczka, N (1998), «In vitro packaging of adeno-associated virus DNA», Journal of virology, 72 (4): 3241–7, PMID 9525651
  • Nony, P; Tessier, J; Chadeuf, G; Ward, P; և այլք: (2001), «Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences», Journal of virology, 75 (20): 9991–4, PMID 11559833 {{citation}}: Explicit use of et al. in: |given4= (օգնություն)
  • Nony, P; Chadeuf, G; Tessier, J; Moullier, P; և այլք: (2003), «Evidence for packaging of rep-cap sequences into adeno- associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles», Journal of virology, 77, PMID 12477885 {{citation}}: Explicit use of et al. in: |given4= (օգնություն); Unknown parameter |Issue= ignored (|issue= suggested) (օգնություն)
  • Philpott, NJ; Giraud-Wali, C; Dupuis, C; Gomos, J; և այլք: (2002), «Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis», Journal of virology, 76 (11), PMID 11991970 {{citation}}: Explicit use of et al. in: |given4= (օգնություն)
  • Tullis, GE; Shenk, T (2000), «Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size», Journal of virology, 74 (24), PMID 11090148
  • Kyostio, SR; Owens, RA; Weitzman, MD; Antoni, BA; և այլք: (1994), «Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels», Journal of virology, 68 (5): 2947–57, PMID 8151765 {{citation}}: Explicit use of et al. in: |given4= (օգնություն)
  • Im, DS; Muzyczka, N (1990), «The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity.», Cell, 61 (3): 447–57, PMID 2159383
  • Im, DS; Muzyczka, N (1992), «Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization», Journal of virology, 66 (2): 1119–28, PMID 1309894
  • Samulski, RJ (2003), «AAV vectors, the future workhorse of human gene therapy», Ernst Schering Research Foundation workshop (43): 25–40, PMID 12894449
  • Trempe, JP; Carter, BJ (1988a), «Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation», Journal of virology, 62 (1): 68–74, PMID 2824856
  • Jay, FT; Laughlin, CA; Carter, BJ (1981), «Eukaryotic translational control: adeno-associated virus protein synthesis is affected by a mutation in the adenovirus DNA-binding protein», Proceedings of the National Academy of Sciences of the United States of America, 78 (5): 2927–31, PMID 6265925
  • Becerra, SP; Rose, JA; Hardy, M; other (1985), «Direct mapping of adeno-associated virus capsid proteins B and C: a possible ACG initiation codon», Proceedings of the National Academy of Sciences of the United States of America, 82 (23): 7919–23, PMID 2999784
  • Cassinotti, P; Weitz, M; Tratschin, JD (1988), «Organization of the adeno-associated virus (AAV) capsid gene: mapping of a minor spliced mRNA coding for virus capsid protein 1», Virology, 167 (1): 176–84, PMID 2847413
  • Muralidhar, S; Becerra, SP; Rose, JA (1994), «Site-directed mutagenesis of adeno-associated virus type 2 structural protein initiation codons: effects on regulation of synthesis and biological activity», Journal of virology, 68 (1): 170–6, PMID 8254726
  • Trempe, JP; Carter, BJ (1988b), «Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein», Journal of virology, 62 (9): 3356–63, PMID 2841488
  • Rabinowitz, JE; Samulski, RJ (2000), «Building a better vector: the manipulation of AAV virions», Virology, 278 (2): 301–8, PMID 11118354
  • Girod, A; Wobus, CE; Zádori, Z; others (2002), «The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity», The Journal of general virology, 83 (5): 973–8, PMID 11961250
  • Warrington, KH,Jr; Gorbatyuk, OS; Harrison, JK; others (2004), «Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus», Journal of virology, 78 (12): 6595–609, PMID 15163751{{citation}}: CS1 սպաս․ բազմաթիվ անուններ: authors list (link)
  • Xie, Q; Bu, W; Bhatia, S; others (2002), «The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy», Proceedings of the National Academy of Sciences of the United States of America, 99 (16): 10405–10, PMID 12136130
  • Mori, S; Wang, L; Takeuchi, T; Kanda, T (2004), «Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein», Virology, 330 (2): 375–83, PMID 15567432
  • Bartlett, JS; Samulski, RJ; McCown, TJ; others (1998), «Selective and rapid uptake of adeno-associated virus type 2 in brain», Human gene therapy, 9 (8): 1181–6, PMID 9625257
  • Fischer, AC; Beck, SE; Smith, CI; others (2003), «Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques», Molecular therapy : the journal of the American Society of Gene Therapy, 8 (6): 918–26, PMID 14664794
  • Nicklin, SA; Buening, H; Dishart, KL; others (2001), «Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells», Molecular therapy : the journal of the American Society of Gene Therapy, 4 (3): 174–81, PMID 11545607
  • Rabinowitz, JE; Xiao, W; Samulski, RJ (1999), «Insertional mutagenesis of AAV2 capsid and the production of recombinant virus», Virology, 265 (2): 274–85, PMID 10600599
  • Shi, W; Bartlett, JS (2003), «RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism», Molecular therapy : the journal of the American Society of Gene Therapy, 7 (4): 515–25, PMID 12727115
  • Wu, P; Xiao, W; Conlon, T; others (2000), «Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism», Journal of virology, 74 (18): 8635–47, PMID 10954565
  • Manno, CS; Chew, AJ; Hutchison, S; others (2003), «AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B», Blood, 101 (8): 2963–72, PMID 12515715
  • Richter, M; Iwata, A; Nyhuis, J; others (2000), «Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo», Physiological genomics, 2 (3): 117–27, PMID 11015590
  • Koeberl, DD; Alexander, IE; Halbert, CL; others (1997), «Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors», Proceedings of the National Academy of Sciences of the United States of America, 94 (4): 1426–31, PMID 9037069
  • Qing, K; Mah, C; Hansen, J; other (1999), «Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2», Nature medicine, 5 (1): 71–7, PMID 9883842
  • Summerford, C; Samulski, RJ (1998), «Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions», Journal of virology, 72 (2): 1438–45, PMID 9445046
  • Summerford, C; Bartlett, JS; Samulski, RJ (1999), «AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection», Nature medicine, 5 (1): 78–82, PMID 9883843
  • Qiu, J; Handa, A; Kirby, M; Brown, KE (2000), «The interaction of heparin sulfate and adeno-associated virus 2», Virology, 269 (1): 137–47, PMID 10725206
  • Pajusola, K; Gruchala, M; Joch, H; other (2002), «Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells», Journal of virology, 76 (22): 11530–40, PMID 12388714
  • Gao, GP; Alvira, MR; Wang, L; other (2002), Proceedings of the National Academy of Sciences of the United States of America, 99 (18): 11854–9, PMID 12192090 {{citation}}: Missing or empty |title= (օգնություն)
  • Halbert, CL; Allen, JM; Miller, AD (2001), «Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors», Journal of virology. (J Virol) Jul; ():, 75 (14): 6615–24, PMID 11413329{{citation}}: CS1 սպաս․ հավելյալ կետադրություն (link)
  • Rabinowitz, JE; Bowles, DE; Faust, SM; other (2004), «Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups», Journal of virology, 78 (9): 4421–32, PMID 15078923
  • Chen, S; Kapturczak, M; Loiler, SA; others (2005), «Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors», Human gene therapy, 16 (2): 235–47, PMID 15761263
  • Kaludov, N; Brown, KE; Walters, RW; others (2001), «Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity», Journal of virology, 75 (15): 6884–93, PMID 11435568
  • Di Pasquale, G; Davidson, BL; Stein, CS; others, «Identification of PDGFR as a receptor for AAV-5 transduction», Nature medicine, 9 (10): 1306–12, PMID 14502277
  • Zaiss, AK; Liu, Q; Bowen, GP; others (2002), «Differential Activation of Innate Immune Responses by Adenovirus and Adeno-Associated Virus Vectors», Journal of Virology, 76 (9): 4580–90, PMID 11932423
  • Zaiss, AK; Muruve, DA (2005), «Immune responses to adeno-associated virus vectors», Current Gene Therapy, 5 (3): 323–31, PMID 15975009
  • High, KA; Mannos, CS; Pierce, GF; Others (2006), «Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response», Nature Medicine, 12 (3): 342–47, PMID 16474400
  • High, KA; Sabatino, DE; Mingozzi, F; Others (2005), «Identification of Mouse AAV Capsid-Specific CD8+ T Cell Epitopes», Molecular Therapy, 12 (6): 1023–33, PMID 16263332
  • Rohr, UP; Kronenwett, R; Grimm, D; others (2002), «Primary human cells differ in their susceptibility to rAAV-2-mediated gene transfer and duration of reporter gene expression», Journal of virological methods, 105 (2): 265–75, PMID 12270659
  • Matsushita, T; Elliger, S; Elliger, C; others (1998), «Adeno-associated virus vectors can be efficiently produced without helper virus», Gene therapy, 5 (7): 938–45, PMID 9813665
  • Myers, MW; Laughlin, CA; Jay, FT; other (1980), «Adenovirus helper function for growth of adeno-associated virus: effect of temperature- sensitive mutations in adenovirus early gene region 2», Journal of virology, 35 (1): 65–75, PMID 6251278
  • Handa, H; Carter, BJ (1979), «Adeno-associated virus DNA replication complexes in herpes simplex virus or adenovirus-infected cells», The Journal of biological chemistry, 254 (14): 6603–10, PMID 221504
  • Yalkinoglu, AO; Heilbronn, R; Bürkle, A; other (1988), «DNA amplification of adeno-associated virus as a response to cellular genotoxic stress», Cancer research, 48 (11): 3123–9, PMID 2835153
  • Yakobson, B; Koch, T; Winocour, E (1987), «Replication of adeno-associated virus in synchronized cells without the addition of a helper virus», Journal of virology, 61 (4): 972–81, PMID 3029431
  • Yakobson, B; Hrynko, TA; Peak, MJ; Winocour, E (1989), «Replication of adeno-associated virus in cells irradiated with UV light at 254 nm», Journal of virology, 63 (3): 1023–30, PMID 2536816
  • Duan, D; Sharma, P; Yang, J; others (1998), «Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue», Journal of virology, 72 (11): 8568–77, PMID 9765395

pubmed.ncbi.nlm.nih.gov

oxfordjournals.org

humrep.oxfordjournals.org

web.archive.org